Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer - Wikidata - wikimedia - TriplyDB

Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer

Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer

http://www.wikidata.org/entity/Q34610496

about

Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo.Orthotopic pancreatic tumors detected by optoacoustic tomography using Syndecan-1.Micro-ultrasound for preclinical imaging.Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5)Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.Dynamic contrast enhanced magnetic resonance imaging of an orthotopic pancreatic cancer mouse model Molecular targeted approaches for treatment of pancreatic cancer.Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy Effect of anti-DR5 and chemotherapy on basal-like breast cancer.Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging.Monoclonal antibodies in the treatment of pancreatic cancer.Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis Apoptosis pathways and their therapeutic exploitation in pancreatic cancer.Tumor Necrosis Factor-related apoptosis-inducing ligand (TRAIL) Receptor-1 and Receptor-2 agonists for cancer therapy.Combined modality therapy with TRAIL or agonistic death receptor antibodies.Corosolic acid analogue, a natural triterpenoid saponin, induces apoptosis on human hepatocarcinoma cells through mitochondrial pathway in vitro.A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models.Toxic effects of xylazine on endothelial cells in combination with cocaine and 6-monoacetylmorphine.Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo.Targeting apoptosis signaling in pancreatic cancer

P2860

Q30372356-85CF3F2C-BAA3-4EC9-A3A2-D9CA15AECB7F Q30394919-4C1B4B9C-259E-4D0C-88B8-D5DB8447337B Q30425612-2DEC2DE9-4BF6-4973-8DA1-3DEBC08CD5D0 Q33906524-DE67A6CF-CD1F-4545-8CF2-BB5743484053 Q34139691-F3099ED3-9462-4619-9B84-AC2F74F85377 Q34286070-AD98EEA7-BA58-4CEF-B0AF-F9EBF42794F5 Q34412950-09E231E6-0B72-4759-B745-A731C96C299A Q35751307-5716C1DD-B1DC-4770-93BB-75C859DBB848 Q35970722-9091D350-64C9-4414-9E9D-0B0D0102EB67 Q36174910-33D074FD-052C-4351-B3B7-3D82660E93D8 Q36653033-4490C269-897D-4BC7-B130-BB0D27ECA792 Q36731275-612600E7-9098-49F0-B3AE-FEB2B7CB82E4 Q37001575-F5999D9A-F12B-4BD1-BFAF-E57AA7921375 Q37355568-A3770A28-0F3A-439E-91B5-81A0B930B7CF Q37411831-8A866119-8F64-4D93-8822-938E12E0E07F Q37453523-642FDCA9-2902-48EC-9C54-125D888271FA Q37621564-6BCA890D-D06A-4323-B0DE-2052D450E388 Q37832083-76294543-4E86-4616-9B35-BFB41341D6B9 Q38799448-6CA3D3F8-F051-46CA-8E7D-11EAE0B0A917 Q38820739-2078ABF5-379C-4E88-8AC5-7B0580692E35 Q38975853-4D49CE9A-AA0B-46C4-9931-51F34C92B434 Q39983073-A83B1CD4-232C-4BA6-9B6F-A6F6FDA1910E Q41872813-4BDF3068-B79B-4F45-B674-E601370E5CCC Q42040100-7F3C7496-5C7F-42F8-A469-E75A67F3389D

P2860

Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer

http://www.wikidata.org/entity/Q34610496

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

Combination treatment with TRA ...... pic model of pancreatic cancer

@ast

Combination treatment with TRA ...... pic model of pancreatic cancer

@en

Combination treatment with TRA ...... pic model of pancreatic cancer

@nl

type

label

Combination treatment with TRA ...... pic model of pancreatic cancer

@ast

Combination treatment with TRA ...... pic model of pancreatic cancer

@en

Combination treatment with TRA ...... pic model of pancreatic cancer

@nl

prefLabel

Combination treatment with TRA ...... pic model of pancreatic cancer

@ast

Combination treatment with TRA ...... pic model of pancreatic cancer

@en

Combination treatment with TRA ...... pic model of pancreatic cancer

@nl

P1433

Q34610496-75D98C41-2CF8-40DA-8BAB-C57080B2BC3D

P1476

Q34610496-4C5A706C-331C-4F56-BA7D-EB6E80372CDA

P2093

Q34610496-03306D5F-91B6-4710-BE1D-52A1E7BCD85A

Q34610496-0A4CD961-51F2-4F86-97D9-F45056C1B0E4

Q34610496-235297E1-118C-42AB-AF65-A82A24FC1856

Q34610496-33A56319-F343-4D73-8ED9-8EFBA3BED84C

Q34610496-7A83DE14-A65F-4A3B-800F-9C4C3F899089

Q34610496-7FCECF1E-8D6E-458C-9FDB-133C4C7EC590

Q34610496-ACEAF9BF-B903-4570-8F5E-E500ACEC70C4

Q34610496-C2C15487-D38A-4D4D-B074-844E792915B6

Q34610496-C95D665C-F2C0-4280-A67A-87A9BEE78EFD

P2860

Q34610496-02071729-5CEC-45A0-A1EF-34673695B6CB

Q34610496-03E8DE24-5D10-454E-81E7-6EAF7E96DF8B

Q34610496-05AFAE46-746C-4D94-B31F-23E1593D4B3E

Q34610496-068FEDE7-56CE-4987-8411-844CA039CC0D

Q34610496-094471B5-A6B4-4A0C-AC28-1A1A03DCA135

Q34610496-11644603-36F6-4E21-B6A9-7FC834DC1499

Q34610496-11CF0105-8ABF-4AC2-B15E-0F4B26FE5623

Q34610496-16919FC8-EE3A-430C-9C6E-801ABDB2318B

Q34610496-1EF63E0C-F462-44FB-ADBF-2FBA6356E5FD

Q34610496-2528B09E-EA9E-4432-A196-5E0D4A7A1FF3

P304

Q34610496-5F64ABB3-C454-45DD-8AF6-ABAA1F92CD59

P31

Q34610496-1E82DC09-5146-46A1-A14C-6B3F4E10BB36

P356

Q34610496-74BCC430-D681-4F50-82D9-EB79FEA5157B

P407

Q34610496-7E183F2D-CB9E-4C67-A3D5-EA4C93F9B758

P433

Q34610496-10580A50-9515-431D-A3D4-E8495043F96A

P478

Q34610496-26524879-8497-4CDC-983D-D11AD7E39BE7

P50

Q34610496-57196C42-F1FB-45EE-B006-DB37F5C68A24

Q34610496-C5EFC98E-1F0F-4C10-AC7B-556047983DE8

P577

Q34610496-71685231-9353-4CF9-9FD9-4AC928A46453

P698

Q34610496-91062976-8233-4C60-B1B3-6D8E0896096F

P921

Q34610496-92BF2C84-064C-4BC3-9F2B-309756F8A4B9

P932

Q34610496-5AFD59E5-E875-49EF-911C-F2359ACF7164

P356

1078-0432.CCR-07-1075

P1433

Clinical Cancer Research

P1476

Combination treatment with TRA ...... pic model of pancreatic cancer

@en

P2093

Jeffrey C Sellers

http://www.w3.org/2001/XMLSchema#string

Joshua W Long

http://www.w3.org/2001/XMLSchema#string

Leo Christopher DeRosier

http://www.w3.org/2001/XMLSchema#string

Patsy G Oliver

http://www.w3.org/2001/XMLSchema#string

Selwyn M Vickers

http://www.w3.org/2001/XMLSchema#string

Tong Zhou

http://www.w3.org/2001/XMLSchema#string

Wenquan Wang

http://www.w3.org/2001/XMLSchema#string

William E Grizzle

http://www.w3.org/2001/XMLSchema#string

Zhi-Qiang Huang

http://www.w3.org/2001/XMLSchema#string

P2860

The receptor for the cytotoxic ligand TRAIL

Identification and characterization of a new member of the TNF family that induces apoptosis

HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo

Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

A novel receptor for Apo2L/TRAIL contains a truncated death domain

P304

5535s-5543s

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-1075

http://www.w3.org/2001/XMLSchema#string

P407

P433

18 Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Donald J Buchsbaum

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17875786

http://www.w3.org/2001/XMLSchema#string

P921

P932

3045836

http://www.w3.org/2001/XMLSchema#string